Single-Patient Trials, Extemporaneously Compounded Products and Pharmaceutical Care
Author(s): Fassett William E
Issue: Nov/Dec 2003 - Compounding for Investigational Studies
View All Articles in Issue
Page(s): 441-447
Download in electronic PDF format for $75
Abstract: Documentation of the achievement of desired outcomes is a key element of pharmaceutical care, and an important tool is assessing outcome is the use of single-patient trials, controlled trials of drug therapies in individual patients. This article discusses the philosophical and practical basis for including the preparation of extemporaneously compounded dosage forms as a component of pharmaceutical care and discusses how single-patient trials are conducted. The main topics of discussion include pharmaceutical care and the pharmaceutical-care process, the alternative-therapies compromise, documentation, the role of single-patient trials, requirements for single-patient trials, a primer on the conduct of single-patient trials, study designs and analysis (with three figures illustrating different designs) and establishing a single-patient-trial service. References provide a list of useful resources for pharmacists who wish to conduct single-patient trials. The author concludes that a well-designed single-patient trial can provide the crucial evidence needed to support therapeutic decision making when marketed products are not available to meet the needs of a specific patient and that a pharmacist’s ability to provide such services is a useful contribution to delivery of pharmaceutical care.
Related Keywords:
Alternative therapies, in drug-related care, Extemporaneously compounded products, Single-patient trials, Single-patient trial service, establishing, Trials, single-patient, designing, conducting, and analyzing
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Single-Patient Trials, Extemporaneously Compounded Products and Pharmaceutical Care
Fassett William E
|
Nov/Dec 2003
Pg. 441-447
|
Patient-centered Care as Value-added Service by Compounding Pharmacists
McPherson Timothy B, Fontane Patrick E, Day Jonathan R
|
Jul/Aug 2013
Pg. 339-343
|
Five Compounds for Treating Diabetes-Related Conditions
Meece Jerry
|
May/Jun 2003
Pg. 170-174
|
Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial
Rabi Joseph, Minori Joshua, Abad Hasan, Lee Ray, Gittler Michelle
|
Nov/Dec 2016
Pg. 517-520
|
Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports
Haase Mark R, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George
|
Jan/Feb 2009
Pg. 14-18
|
Home Infusion: Overview of the Infusion Patient-Care Process
Kennedy Steve
|
Jul/Aug 2011
Pg. 270-276
|
Compounding for the Pediatric Patient
Allen Loyd V Jr
|
Mar/Apr 1997
Pg. 84-86
|
Single Center Experience with Robot Technologies for Sterile Compounding: A Retrospective Review
Milibari Loay, Cotugno Michael, Belisle Caryn, Rocchio Megan, Patterson Robert F, Chacon Pablo, Fanikos John, Vo Peter
|
Jul/Aug 2020
Pg. 346-351
|
Azstarys in Ora-Blend Single Dose
Allen Loyd V Jr
|
May/Jun 2022
Pg. 233
|
Patient Satisfaction with Pharmacist Intervention and Consultation in HRT
DiMaggio Jennifer Lyn, Reed-Kane Dana
|
Jul/Aug 2003
Pg. 258-263
|
Compounded Medications in a Hospital Setting: Patient Counseling and Staff Education
McElhiney Linda F
|
May/Jun 2009
Pg. 224-229
|
Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists
Huffman DC, Holmes Erin R
|
Jan/Feb 2008
Pg. 74-82
|
Pharmacogenomics: The End of Trial-and-Error Medicine?
Vail Jane
|
Jan/Feb 2007
Pg. 59-65
|
Patient Interest in Pharmacist-Provided Menopause and Hormone Replacement Therapy Consultations
Branvold Andrea, Barner Jamie C
|
Nov/Dec 2003
Pg. 490-494
|
Menopausal Women's Access Path to Bioidentical Hormone Replacement Therapy: An Exploratory Study
Moro Doris, Young Wendy, Stein Richard, Isaac Winston, Goodman Deborah
|
Mar/Apr 2010
Pg. 165-170
|
Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists
Huffman DC, Holmes Erin R
|
Nov/Dec 2006
Pg. 462-468
|
Compounding with Biotechnology Products, Part 2: Product-specific Considerations
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 446-466
|
Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy
Kochanowska-Karamyan Anna J
|
Sep/Oct 2016
Pg. 367-374
|
Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program
Okeke Claudia C, Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 328-331
|
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers
Allen Loyd V Jr, Williams LaVonn A
|
Jul/Aug 2012
Pg. 294-298
|
Return to Top |